Clinical trial
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
NCT00257426 · UNC Lineberger Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00257426 |
|---|---|
| Title | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer |
| Official title | A Phase II Study of Octreotide Acetate for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug |
| Interventions | octreotide acetate |
| Enrollment | 31 |
| Start date | Jul 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Sep 1, 2009 |
| First posted | Nov 22, 2005 |
| Last update posted | Feb 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: